Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Status
- RECRUITING
- Phase
- PHASE3
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Status
- RECRUITING
- Phase
- PHASE1
Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
- Status
- RECRUITING
- Phase
- PHASE2
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE4
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
- Status
- RECRUITING
- Phase
- N/A
A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
- Status
- TERMINATED
- Phase
- PHASE2
CARE1 Pragmatic Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3